Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical products. Harrow also owns and operates ImprimisRx, the leading U.S. ophthalmic‑focused pharmaceutical compounding business, which also serves as a mail-order pharmacy licensed to ship prescription medications in all 50 states. Harrow has non-controlling equity positions in Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc., companies that began as subsidiaries of Harrow. Harrow also owns royalty rights in four late-stage drug candidates being developed by Surface and Melt.

Manufacturing

Pharmaceutical

Harrow

Mark L. Baum

Garrett S.

Mark Mannebach

Kim Barratt

Dennis E. Saadeh

Andrew R. Boll

John P. Saharek

The Sales and Marketing team at Harrow is responsible for driving the commercial success of the company's ophthalmic prescription therapies. This team works on market access, strategic account management, direct sales, and brand marketing for Harrow's portfolio, including FDA-approved products and compounded pharmaceuticals. They develop and execute strategic initiatives to increase product adoption, engage key stakeholders, manage territories, and enhance market presence to ensure that Harrow's innovative and affordable eye care solutions reach patients nationwide.

Sales and Marketing

Leadership Team

Sales and Marketing

About

Team members

Other teams at Harrow

Leadership Team